Table 2 Association trend of WMH risk loci with white matter microstructures in young adults.

From: Cerebral small vessel disease genomics and its implications across the lifespan

Variables

Region

Nearest gene

PSMD (10−4 mm²s−1)

FA

MD (10−4 mm²s−1)

RD (10−4 mm²s−1)

AxD (10−4 mm²−1)

Β

SE

P

β

SE

P

β

SE

P

β

SE

P

β

SE

P

wGRS

  

0.077

0.022

4.53E-04

−0.012

0.002

2.53E-07

0.111

0.026

1.66E-05

0.142

0.028

5.38E-07

0.050

0.031

1.09E-01

SNPsa

                

rs10786772

10q24.33

SH3PXD2A

0.019

0.005

9.98E-05

−0.002

0.001

3.70E-04

0.022

0.006

1.11E-04

0.025

0.006

7.16E-05

0.017

0.007

1.86E-02

rs6503417

17q21.31

NMT1

0.015

0.005

2.25E-03

−0.002

0.001

2.20E-03

0.021

0.006

1.52E-04

0.023

0.006

2.13E-04

0.018

0.007

7.06E-03

rs830179

3q27.1

KLHL24

0.012

0.005

1.52E-02

−0.001

0.001

8.81E-02

0.014

0.006

1.32E-02

0.014

0.006

2.56E-02

0.015

0.007

2.94E-02

rs17205972

5q14.2

VCAN

0.030

0.006

3.28E-07

−0.004

0.001

2.29E-09

0.041

0.007

1.80E-09

0.049

0.008

1.20E-10

0.027

0.008

1.23E-03

  1. All models are adjusted for age, sex, the first four principal components for population stratification, and total intracranial volume.
  2. PSMD peak width of skeletonized mean diffusivity, FA fractional anisotropy, MD mean diffusivity, RD radial diffusivity, AxD axial diffusivity, β effect estimate, SE standard error, P P value, wGRS weighted Genetic Risk Score, SNP single nucleotide polymorphism.
  3. aFor individual SNPs, a p value < 2 × 10−3 is considered significant, after multiple testing correction (considering 25 independent loci tested).